
Underwriters Laboratories, (UL) has expanded its medical industry services to include Biocompatibility testing. Biocompatibility test reports are part of the regulatory submissions required by the regulatory bodies in the three major medical device markets – United States FDA, Japan MH LW, and European Union Notified Bodies – and support UL's leadership as an end-to-end regulatory and certification services provider for the global medical industry.
Medical and IVD manufacturers can now receive a complete test package through UL's network for all the tests necessary to complete technical file submissions. By working with UL, manufacturers may customize test protocols to minimize testing, samples required and time, while meeting multiple country preferred test methods.
Through its relationships, UL also offers customers access to microbiology, analytical and bioanalytical chemistry, pharmaceutical analysis, and extractable & leachable analysis.
To find out more about UL's biocompatibility and analytical testing services and download your copy of the matrix of requirement for FDA, ISO and MHLW visit: ul.com/hitech/ biocompatibility.
Get curated news on YOUR industry.
Enter your email to receive our newsletters.
Explore the August 2008 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Pioneering battery-free cardiac implants
- KBC Tools & Machinery marks its 60th anniversary, Founder’s Day
- Address the challenges of machining high-temperature aerospace components
- Elevate your manufacturing operations with April’s Manufacturing Lunch + Learn
- AdvaMed statement on tariff announcement
- Collets – Not all are created equal
- ENGEL expands production capacities in the Americas; new plant opened in Mexico
- MFI brings fast, high-polishing additive parts finishing to Rapid + TCT 2025